Skip to content

6FIT

Active
Private limited companyfounded 200916 yrs activeRue Pré Delcourt 43, 1325 Chaumont-Gistoux, BelgiumKBO/BCE: BE 0820.591.195

6FIT has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €80k and a net result of €35k. Equity is growing by ~7.5% per year across the filed fiscal years. Its solvency ranks better than 40% of 517 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
100 / 100
Excellent▲ +22 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100▲+38
Solvency96▲+26
Growth52▲+20
Stability100
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €8k at 30 days acceptable
Liquidity ample (current ratio 2.03 against 1.27 in 2024), and 49.3% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Seven signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 71
Relative position
BE, all sectors
reference
Sector 71
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 16 years 0 20 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
50.7%
Return on assets
21.9%
Age of the figures
8 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-06-2026, 60 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
60 d early
2024
83 d early
2023
56 d early
2022
25 d early
2021
83 d early
2020
36 d early
2019
37 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
13-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€35k▲ 513%
2024 · €6k
2018: €47k 2019: €5k 2020: €-10k 2021: €7k 2022: €17k 2023: €32k 2024: €6k
2018 → 2025
Working capital
€42k▲ 183%
2024 · €15k
2018: €47k 2019: €24k 2020: €10k 2021: €9k 2022: €32k 2023: €5k 2024: €15k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€34k-€51k▲ 51.5%€46k▼ 10.0%€46k=€80k▲ 76.1%
Operating result€5k-€26k▲ 446%€40k▲ 55.6%€9k▼ 76.7%€49k▲ 421%
Net result€7k-€17k▲ 143%€32k▲ 84.3%€6k▼ 82.2%€35k▲ 513%
Result per fiscal year
Operating resultNet result
€0€20k€40kOperating result 2021: €5k€5kNet result 2021: €7k€7kOperating result 2022: €26k€26kNet result 2022: €17k€17kOperating result 2023: €40k€40kNet result 2023: €32k€32kOperating result 2024: €9k€9kNet result 2024: €6k€6kOperating result 2025: €49k€49kNet result 2025: €35k€35k20212022202320242025
The operating result recovers in 2025; 2025 is 421% above 2024 and is the highest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €159k
Fixed assets €76k▲ 90.1%
Current assets €82k▲ 19.5%
Equity and liabilities €159k
Equity €80k▲ 76.1%
Debt €78k▲ 23.4%
The debt ratio falls from 58.1% to 49.3%: equity grows faster than debt.
Key figures and ratios
2025 value · change against 2024
EBITDA
€66k
2024 · €25k
Cash flow
€52k
2024 · €22k
Solvency
50.7%
2024 · 41.9%
Current ratio
2.03
2024 · 1.27
Quick ratio
2.03
2024 · 1.27
Debt / equity
0.97
2024 · 1.39
ROE
43.2%
2024 · 12.4%
ROA
21.9%
2024 · 5.2%
Interest coverage
66.93
2024 · 18.69
Debt
€78k
2024 · €63k
Debt ≤ 1 year
€41k
2024 · €54k
Debt > 1 year
€38k
2024 · €9k
Income taxes
€13k
2024 · €2k
Staff costs
€58k
2024 · €88k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€109k€159k
Fixed assets21/28€40k€76k
Intangible fixed assets21€2k€0
Tangible fixed assets22/27€38k€76k
Plant, machinery and equipment23€5k€4k
Furniture and vehicles24€33k€23k
Other tangible fixed assets26-€49k
Financial fixed assets28€136€136=
Current assets29/58€69k€82k
Amounts receivable within one year40/41€34k€20k
Trade receivables40€11k€0
Other amounts receivable41€22k€20k
Cash at bank and in hand54/58€34k€61k
Deferred charges and accrued income490/1€1k€1k
Equity and liabilities
Total equity and liabilities10/49€109k€159k
Equity10/15€46k€80k
Contributions10/11€6k€6k=
Reserves13€19k€54k
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Distributable reserves133€17k€52k
Profit (loss) carried forward14€20k€20k=
Amounts payable17/49€63k€78k
Amounts payable after more than one year17€9k€38k
Financial debts170/4€9k€38k
Amounts payable within one year42/48€54k€41k
Current portion of amounts payable after more than one year42€7k€15k
Financial debts43€408-
Credit institutions430/8€408-
Trade debts44€10k€10k
Suppliers440/4€10k€10k
Taxes, remuneration and social security45€31k€15k
Taxes450/3€10k€13k
Remuneration and social security454/9€21k€2k
Other amounts payable47/48€6k€328
Income statement Code20242025
Remuneration, social security and pensions62€88k€58k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€16k€17k
Other operating charges640/8€461€561
Gross operating margin9900€114k€124k
Operating profit (loss)9901€9k€49k
Financial income75/76B€1€0
Recurring financial income75€1€0
Financial charges65/66B€1k€981
Recurring financial charges65€1k€981
Profit (loss) for the period before taxes9903€8k€48k
Income taxes67/77€2k€13k
Profit (loss) for the period9904€6k€35k
Profit (loss) for the period to be appropriated9905€6k€35k
Appropriation of the result
Profit (loss) to be appropriated9906€26k€55k
Profit (loss) brought forward from the previous period14P€20k€20k=
Transfer to equity691/2-€35k
To other reserves6921-€35k
Profit to be distributed694/7€6k-
Return on contributions (dividend)694€6k-

The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
01-06
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
09-05
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
05-06
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
06-07
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial Liquidity triplescurrent ratio 4.04
Current ratio from 1.37 to 4.04; short-term debt falls from €25k to €11k.
09-05
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial Back to profitnet €7k
Net result €7k after one loss-making year.
25-06
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial Weakest financial yearnet €-10k ▼285%
Net result drops to €-10k, the lowest in the series; recovery starts the following year.
31-12
Financial Liquidity times 11current ratio 17.87
Current ratio from 1.58 to 17.87; short-term debt falls from €42k to €574.
24-06
NBB filing Annual accounts filed
fiscal year 2019 · full schema
2019
17-06
NBB filing Annual accounts filed
fiscal year 2018 · full schema
2018
28-06
NBB filing Annual accounts filed
fiscal year 2017 · full schema
2017
15-06
NBB filing Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
7 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Chaumont-Gistoux · 1 establishment unit since 2009
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Rue Pré Delcourt 431325 Chaumont-Gistoux
Ground area
7,379 m²
Building footprint
251 m²
2 parcels, Wallonia. Linked by address, not a title deed.
1 establishment unit
6FIT
Rue des Comognes 4, 5340 GesvesManufacture of basic pharmaceutical products and pharmaceutical preparations
since 20092.182.861.373
2 parcels
Wallonia 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
92092A0078/00L000 Wallonia 4,381 m² 1 · 142 m² -
25018B0388/00B000 Wallonia 2,999 m² 1 · 109 m² -
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 11,505 companies in sector 71121 we hold annual accounts for 6,525. 5,143 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded17-11-2009
Fiscal year end31-12
Activities, NACEBEL
71121Engineering and related technical consultancy, excluding land surveyors
72101Research and development on biotechnology
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
Sources
Crossroads Bank for EnterprisesNational Bank · 16 filingsAddress and cadastre registers

Data from official sources, last processed on 13-09-2026. Scores and ratios are computed by Checked and are not a credit decision.